Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

JPMorgan Lifts Haemonetics Price Target to $86.00

Guavy AI Editorial Team
Instruments
JPM
Share

Haemonetics (NYSE:HAE) has had its price target increased by JPMorgan Chase & Co. from $62.00 to $86.00 in a recent research report.

The firm currently has a 'neutral' rating on the medical instruments supplier's stock, indicating a potential upside of 0.17% from the company's current price.

Haemonetics reported quarterly earnings that exceeded analysts' consensus estimates, with $1.14 earnings per share compared to the expected $1.08.

More on Stocks

Stocks just now

PG Stock Sentiment Shifts Amid Strong Near-Term Signals

Stocks 1m ago

Analysts Weigh In on Consumer Goods: Herbalife, P&G, and Costco

Stocks 2m ago

Dimon Pushes Cross-Industry AI Safety Effort Amid Growing Cyber Threats

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy